ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $407,000 | -4.9% | 222,603 | -26.7% | 0.02% | +37.5% |
Q4 2021 | $428,000 | -89.0% | 303,811 | -84.8% | 0.02% | -91.3% |
Q4 2020 | $3,900,000 | -18.4% | 2,000,000 | 0.0% | 0.18% | -47.4% |
Q3 2020 | $4,780,000 | -18.4% | 2,000,000 | 0.0% | 0.35% | -25.4% |
Q2 2020 | $5,860,000 | -49.1% | 2,000,000 | -50.0% | 0.47% | -30.8% |
Q1 2020 | $11,520,000 | +311.4% | 4,000,000 | +471.4% | 0.68% | +111.9% |
Q4 2019 | $2,800,000 | -55.8% | 700,000 | -50.9% | 0.32% | -54.6% |
Q3 2019 | $6,338,000 | +15.0% | 1,424,378 | 0.0% | 0.70% | +40.7% |
Q2 2019 | $5,512,000 | +80.7% | 1,424,378 | +76.9% | 0.50% | +80.9% |
Q1 2019 | $3,051,000 | +58.6% | 805,000 | 0.0% | 0.28% | +136.8% |
Q4 2018 | $1,924,000 | -61.5% | 805,000 | 0.0% | 0.12% | -63.9% |
Q3 2018 | $4,999,000 | +25.3% | 805,000 | -9.0% | 0.32% | +20.0% |
Q2 2018 | $3,991,000 | +7.8% | 885,000 | +9.9% | 0.27% | -17.4% |
Q1 2018 | $3,703,000 | +21.4% | 805,000 | -15.3% | 0.33% | +27.2% |
Q4 2017 | $3,050,000 | – | 950,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |